USP Drug Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
   Aminoglycosides
   Beta-lactam, Cephalosporins
   Beta-lactam, Penicillins
   Carbapenems
   Macrolides
     Azithromycin [DG:DG00606]
     Clarithromycin [DG:DG00605]
     Erythromycin [DG:DG00436]
       D00140  Erythromycin (JP17/USP/INN)
       D01361  Erythromycin ethylsuccinate (JP17/USP)
       D02009  Erythromycin lactobionate (JP17/USP)
       D02184  Erythromycin stearate (JP17/USP)
     Fidaxomicin
   Quinolones
   Sulfonamides
   Tetracyclines
   Antibacterials, Other
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
   Acne and Rosacea Agents
   Dermatitis and Pruitus Agents
   Topical Anti-infectives
     Antibacterials, dermatological
       Clindamycin [DG:DG00435]
       Erythromycin [DG:DG00436]
         D00140  Erythromycin (JP17/USP/INN)
         D01361  Erythromycin ethylsuccinate (JP17/USP)
         D02009  Erythromycin lactobionate (JP17/USP)
         D02184  Erythromycin stearate (JP17/USP)
       Benzoyl Peroxide
       Dapsone
       Mafenide [DG:DG00404]
       Mupirocin [DG:DG00402]
       Ozenoxacin
       Retapamulin
     Antifungals, dermatological
     Antivirals, dermatological
   Pediculicides/Scabicides
   Dermatological Agents, Other
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Adrenal)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
   Ophthalmic Anti-allergy Agents
   Intraocular Pressure Lowering Agents
   Ophthalmic Anti-Infectives
     Antibacterials, Ophthalmic
       Azithromycin [DG:DG00606]
       Bacitracin [DG:DG00400]
       Besifloxacin
       Ciprofloxacin [DG:DG00617]
       Erythromycin [DG:DG00436]
         D00140  Erythromycin (JP17/USP/INN)
         D01361  Erythromycin ethylsuccinate (JP17/USP)
         D02009  Erythromycin lactobionate (JP17/USP)
         D02184  Erythromycin stearate (JP17/USP)
       Gatifloxacin [DG:DG00628]
       Gentamicin [DG:DG00401]
       Levofloxacin [DG:DG00624]
       Moxifloxacin [DG:DG00626]
       Ofloxacin [DG:DG00616]
       Sulfacetamide Sodium [DG:DG01124]
       Tobramycin [DG:DG00608]
     Antifungal, Ophthalmic
     Antiviral, Ophthalmic
   Ophthalmic Anti-inflammatories
   Ophthalmic Agents, Other
   Ophthalmic Combinations
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 27, 2020
According to the USP Drug Classification 2020

» Japanese version